So years ago, after following the clinical trials of Opzelura (topical), I was excited to see it finally hit the market only to have my stomach sink into the abyss because of the price.
Now, after completion of clinical trial CUV105 and starting CUV107, this looks incredibly promising. It’s paired with narrow band UV-B treatment. Afamelanotide is the hormone Scenesse is using, which is the medical formulation of melanotan-1, a peptide available on the grey market. See where I’m going with this?
Anybody here in the peptide realm have experience or following this at all?